6608 POSTER An expanded access clinical program of erlotinib in patients (pts) with advanced stage IIIb/ IV non-small-cell lung cancer (NSCLC) – an update of a single institution experience

✍ Scribed by Tewes, M.; Gauler, T.; Schuett, P.; Sailer, V.; Bildat, S.; Korfee, S.; Seeber, S.; Eberhardt, W.E.E.

• Book ID: 122492676
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 58 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71436-2